Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.8 USD | +1.72% |
|
-4.10% | -10.71% |
06-20 | Needham Adjusts Price Target on Jazz Pharmaceuticals to $210 From $222, Maintains Buy Rating | MT |
06-20 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.71% | 6.93B | |
+52.70% | 801B | |
+41.58% | 631B | |
-4.86% | 359B | |
+21.96% | 337B | |
+11.47% | 305B | |
+17.72% | 245B | |
+4.46% | 231B | |
+13.13% | 219B | |
+10.46% | 171B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 10